Business
Patient Deaths Show Darker Side of Modern Chinese Medicine
- Regulators wary of trend toward injectable traditional drugs
- The $13 billion sector has seen side effects double since 2011
This article is for subscribers only.
Early on a snowy, winter morning in January 2012, Wu Xiaoliang, a 37-year-old farmer, stopped by his local doctor to remedy a headache. At a small clinic near his village he received two injections made from traditional Chinese herbs. Hours later, villagers saw him struggling to prop himself up on his moped as he drove home. By noon, he was dead.
What killed Wu was later described in an autopsy report as a "drug allergy." But doctors couldn’t pinpoint what he was allergic to because the shots he was given contained dozens, if not hundreds, of different compounds extracted from two herbs.